Aurora Cannabis (ACB) Non Operating Income (2017 - 2025)
Aurora Cannabis (ACB) reported Non Operating Income of -$504111.7 for Q4 2025, down 110.46% year-over-year from $4.8 million in Q4 2024, and up 68.78% quarter-over-quarter from -$1.6 million in Q3 2025.
Aurora Cannabis (ACB) Non Operating Income (2017 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has 9 years of Non Operating Income data on file, last reported at -$504111.7 in Q4 2025.
- Non Operating Income for Q4 2025 came in at -$504111.7, down 110.46% year-over-year; the trailing twelve-month figure through Dec 2025 was $814519.6 (down 96.68% YoY), and the FY2025 annual result was $1.1 million, down 91.08% from the prior year.
- Non Operating Income grew to -$504111.7 in Q4 2025 per ACB's latest filing, from -$1.6 million in the prior quarter.
- Over five years, Non Operating Income peaked at $742.1 million in Q1 2022 and troughed at -$27.3 million in Q3 2021.
- A 5-year average of $44.4 million and a median of $3.4 million in 2025 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2021 and 2022: Non Operating Income tumbled 439.69% in 2021, then jumped 11190.47% in 2022.
- A 5-year view of Non Operating Income shows it stood at $19.7 million in 2021, then sank by 70.96% to $5.7 million in 2022, then plunged by 103.48% to -$199000.0 in 2023, then surged by 2522.61% to $4.8 million in 2024, then tumbled by 110.46% to -$504111.7 in 2025.
- Business Quant data shows ACB's Non Operating Income at -$504111.7 in Q4 2025, -$1.6 million in Q3 2025, and -$1.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 5.71 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -23.23 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | -4.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -504,111.66 |
| Sep 30, 2025 | -1.61 Mn |
| Jun 30, 2025 | -1.28 Mn |
| Mar 31, 2025 | 4.21 Mn |
| Dec 31, 2024 | 4.82 Mn |
| Sep 30, 2024 | -1.59 Mn |
| Jun 30, 2024 | 2.56 Mn |
| Mar 31, 2024 | 18.72 Mn |
| Dec 31, 2023 | -199,000.00 |
| Sep 30, 2023 | 9.02 Mn |
| Dec 31, 2022 | 5.73 Mn |
| Sep 30, 2022 | -877,924.45 |
| Jun 30, 2022 | -5.52 Mn |
| Mar 31, 2022 | 742.10 Mn |
| Dec 31, 2021 | 19.72 Mn |
| Sep 30, 2021 | -27.28 Mn |
| Jun 30, 2021 | 25.03 Mn |
| Mar 31, 2021 | 6.57 Mn |
| Dec 31, 2020 | 6.19 Mn |
| Sep 30, 2020 | 8.03 Mn |